Angiotensin II-dependent vascular alterations in young cardiomyopathic hamsters: Role for oxidative stress

Vascular Pharmacology

Volumn 44, Issue 1, 2006, Pages 22-28

  Escobales, N ^a   Crespo, M J ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Ang II; Cardiomyopathic hamsters; Heart failure; Oxidative stress; Vasculature

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; LOSARTAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARDIOMYOPATHY; CARDIOVASCULAR SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HAMSTER; HEART DISEASE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART OUTPUT MEASUREMENT; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

ACETYLCYSTEINE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIOXIDANTS; AORTA; BLOOD PRESSURE; CARDIOMYOPATHIES; CRICETINAE; DISEASE MODELS, ANIMAL; LOSARTAN; MALE; MESOCRICETUS; NADPH OXIDASE; OXIDATIVE STRESS; SUPEROXIDES;

EID: 29144504447     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2005.09.008     Document Type: Article

References (37)

1. K.R. Chien Stress pathways and heart failure Cell 98 5 1999 555 558
2. R. Coral-Vazquez, R.D. Cohn, S.A. Moore, J.A. Hill, R.M. Weiss, R.L. Davisson, V. Straub, R. Barresi, D. Bansal, R.F. Hrstka, R. Williamson, and K.P. Campbell Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy Cell 98 4 1999 465 474
3. M.J. Crespo, and W.C. De Mello Chronic administration of losartan plus hydrochlorothiazide improves vascular status in young cardiomyopathic hamsters Eur. J. Pharmacol. 420 2001 133 141
4. M.J. Crespo, P.I. Altieri, and N. Escobales Altered vascular function in early stages of heart failure in hamsters J. Card. Fail. 3 4 1997 311 318
5. R.H. Crosbie, R. Barresi, and K.P. Campbell Loss of sarcolemma nNOS in sarcoglycan-deficient muscle FASEB J. 16 13 2002 1786 1791
6. W.C. De Mello, and M.J. Crespo Correlation between changes in morphology, electrical properties, and angiotensin-converting enzyme activity in the failing heart Eur. J. Pharmacol. 378 2 1999 187 194
7. H. Drexler, and B. Hornig Endothelial dysfunction in human disease J. Mol. Cell. Cardiol. 31 1999 51 60
8. N. Escobales, and M.J. Crespo Oxidative-nitrosative stress in hypertension Curr. Vasc. Pharmacol. 3 3 2005 231 246
9. R. Forman, W.W. Parmley, and E.H. Sonneblick Myocardial contractility in relation to hypertrophy and failure in myopathic Syrian hamster J. Mol. Cell. Cardiol. 4 1972 203 211
10. E.W. Gertz Cardiomyopathic Syrian hamster: a possible model of human disease Prog. Exp. Tumor Res 16 1972 242 260
11. S. Goineau, D. Pape, P. Guillo, M.P. Ramee, and E. Bellissant Hemodynamic and histomorphometric characteristics of dilated cardiomyopathy of Syrian hamsters (Bio TO-2 strain) Can. J. Physiol. Pharmac. 79 4 2001 329 337
12. J.A. Gutierrez, S.G. Clark, A.D. Giulumian, and L.C. Fuchs Superoxide anions contribute to impaired regulation of blood pressure by nitric oxide during the development of cardiomyopathy J. Pharmacol. Exp. Ther. 282 3 1997 1643 1649
13. K.H. Holt, L.E. Lim, V. Straub, D.P. Venzke, F. Duclos, R.D. Anderson, B.L. Davidson, and K.P. Campbell Functional rescue of the sarcoglycan complex in the Bio-14.6 hamster using delta-sarcoglycan gene transfer Mol. Cell. 1 1998 841 848
14. Y. Ikeda, M. Martone, Y. Gu, M. Hoshijima, A. Thor, S.S. Oh, K.L. Peterson, and J. Ross Jr. Altered membrane proteins and permeability correlate with cardiac dysfunction in cardiomyopathic hamsters Am. J. Physiol.: Heart Circ. Physiol. 278 4 2000 H1362 H1370
15. D.S. Kahn, G. Rona, and C.I. Chappel Isoproterenol-induced cardiac necrosis Ann. N. Y. Acad. Sci. 156 1 1969 285 293
16. A. Kashiwagi, K. Shinozaki, Y. Nishio, H. Maegawa, Y. Maeno, A. Kanazawa, H. Kojima, M. Haneda, H. Hidaka, H. Yasuda, and R. Kikkawa Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats Am. J. Physiol. 277 40 1999 E976 E983
17. T. Kawada, Y. Nakatsuru, A. Sakamoto, T. Koizumi, W.S. Shin, Y. Okai-Matsuo, J. Suzuki, Y. Uehara, M. Nakazawa, H. Sato, T. Ishikawa, and T. Toyo-oka Strain- and age-dependent loss of sarcoglycan complex in cardiomyopathic hamster hearts and its re-expression by delta-sarcoglycan gene transfer in vivo FEBS Lett. 458 3 1999 405 408
18. D.C. Lindsay, C. Jiang, F. Brunotte, S. Adamopoulos, A.J. Coats, B. Rajagopalan, P.A. Poole-Wilson, and P. Collins Impairment of endothelium-dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol Cardiovasc. Res. 26 1992 694 697
19. D.E. Newby, N.E. Goodfield, A.D. Flapan, N.A. Boon, K.A. Fox, and D.J. Webb Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II Heart 80 1998 134 141
20. T. Nishizawa, M. Iwase, H. Kanazawa, S. Ichihara, G. Ichhara, K. Nagata, K. Obata, K. Kitaichi, T. Yokoi, M. Watanabe, T. Tsunematsu, Y. Ishikawa, T. Murohara, and M. Yokota Serial alterations of β-adrenergic signaling in dilated cardiomyopathic hamsters. Possible role for myocardial oxidative stress Circ. J. 68 2004 1051 1060
21. F. Paganelli, R. Mougenot, and J.M. Maixentt Defective activity and isoform of the Na,K-ATPase in the dilated cardiomyopathic hamster Cell. Mol. Biol. (Noisy-le-Grand) 47 2 2001 255 260
22. C.L. Perreault, A.J. Meuse, L.A. Bentivegna, and J.P. Morgan Abnormal intracellular calcium handling in acute and chronic heart failure: role in systolic and diastolic dysfunction Eur. Heart J. 11 Suppl. C 1990 8 21
23. S. Rajagopalan, S. Kurz, T. Munzel, M. Tarpey, B.A. Freeman, K.K. Griendling, and D.G. Harrison Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NAD(P)H oxidase activation. Contribution to alterations of vasomotor tone J. Clin. Invest. 97 8 1996 1916 1923
24. T. Ryoke, Y. Gu, Y. Ikeda, M.E. Martone, S.S. Oh, E.S. Jeon, K.U. Knowlton, and J. Ross Jr. Apoptosis and oncosis in the early progression of left ventricular dysfunction in the cardiomyopathic hamster Basic Res. Cardiol. 97 1 2002 65 75
25. A. Sakamoto, K. Ono, M. Abe, G. Jasmin, T. Eki, Y. Murakami, T. Masaki, T. Toyo-oka, and F. Hanaoka Both hypertrophic and dilated cardiomyopathies are caused by mutations of the same gene, delta-sarcoglycan in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex Proc. Natl. Acad. Sci. U. S. A. 94 1997 13873 13878
26. M.P. Skatchkov, D. Sperling, U. Hink, A. Mulsch, D.G. Harrison, I. Sindermann, T. Meinertz, and T. Munzel Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production Biochem. Biophys. Res. Commun. 254 2 1999 319 324
27. H.M. Sommers, and R.B. Jennings Experimental acute myocardial infarction: histologic and histochemical studies of early myocardial infarcts induced by temporary or permanent occlusion of a coronary artery Lab. Invest. 13 1964 1491 1503
28. E.H. Sonnenblick, F. Fein, J.M. Capasso, and S.M. Factor Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy Am. J. Cardiol. 55 1985 179B 184B
29. V. Straub, F. Duclos, D.P. Venzke, J.C. Lee, S. Cutshall, C.J. Leveille, and K.P. Campbell Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster Am. J. Pathol. 153 1998 1623 1630
30. J.E. Strobeck, S.M. Factor, A. Bhan, M. Sole, C.C. Liew, F. Fein, and E.H. Sonnenblick Hereditary and acquired cardiomyopathies in experimental animals; mechanical, biochemical and structural features Ann. N. Y. Acad. Sci. 317 1979 59 88
31. N. Tanaka, N. Dalton, L. Mao, H.A. Rockman, K.L. Peterson, K.R. Gottshall, J.J. Hunter, K.R. Chien, and J. Ross Jr. Transthoracic echocardiography in models of cardiac disease in the mouse Circulation 94 5 1996 1109 1117
32. C.B. Treasure, and R.W. Alexander The dysfunctional endothelium in heart failure J. Am. Coll. Cardiol. 22 4 Suppl. A 1993 129A 134A
33. N.C. Trippodo, M. Fox, V. Natarajan, B.C. Panchal, C.R. Dorso, and M.M. Asaad Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure J. Pharmacol. Exp. Ther. 267 1 1993 108 116
34. S. Ülker, P.P. McKeown, and U. Bayraktutan Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities Hypertension 41 2003 534 539
35. M. Ushio-Fukai, A.M. Zafari, T. Fukui, N. Ishizaka, and K.K. Griendling p22phox is a critical component of the superoxide-generating NAD(P)H oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells J. Biol. Chem. 271 38 1996 23317 23321
36. A. Warnholtz, G. Nickenig, E. Schulz, R. Macharzina, J.H. Brasen, M. Skatchkov, T. Heitzer, J.P. Stasch, K.K. Griendling, D.G. Harrison, M. Bohm, T. Meinertz, and T. Munzel Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system Circulation 99 15 1999 2027 2033
37. C.M. Wei, A. Lerman, R.J. Rodeheffer, C.G. McGregor, R.R. Brandt, S. Wright, D.M. Heublein, P.C. Kao, W.D. Edwards, and J.C. Burnett Jr. Endothelin in human congestive heart failure Circulation 89 4 1994 1580 1586